Search clinical trials for: HCV GT1

Total 1332 results

MassBiologics

Terminated

Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C (MBL-HCV1)

Hepatitis C Infection

United States
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.

Completed

A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients

Cirrhosis | Chronic Hepatics C Virus (HCV) Genotype 1 | Non-Cirrhotic | Treatment naïve

China
Assiut University

Unknown

Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity

Covid19
NYU Langone Health

Completed

HCV Positive Heart Donors

Heart Failure

United States
University of California, San Francisco
National Institutes of Health Clinical Center (CC); Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID) and other collaborators

Completed

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant (STOP-CO)

Hepatitis C | HIV | Cirrhosis

United States
Macfarlane Burnet Institute for Medical Research...
Foundation for Innovative New Diagnostics, Switzerland; UNITAID; Myanmar Liver...

Completed

Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar) (CT2)

Hepatitis C

Myanmar
Hasselt University

Unknown

Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA

Hepatitis C | Drug Use

Belgium
Hong Ren
Gilead Sciences

Completed

A Comprehensive HBsAg-positive Patients Centered Screening Strategy (CHARSET)

Hepatitis B and Hepatitis C (Disorder)

China
Drugs for Neglected Diseases
Ministry of Health, Malaysia; Ministry of Health, Thailand; National Science...

Active, not recruiting

Strategic Transformation of the Market of HCV Treatments (STORM-C-1)

Hepatitis C

Malaysia, Thailand
Theravance Biopharma

Completed

TD-6450 MAD Study in HCV Infected Subjects

Hepatitis C | HCV

United States
European Society for Blood and Marrow Transplantation

Completed

Current Treatment of HCV Infection After HSCT

Hepatitis C

France, Spain, Italy
Novartis Pharmaceuticals

Completed

Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients

Liver Transplantation

Belgium, Germany, Italy, United States, Switzerland, Spain, Austria, Czechia, France, Argentina, Finland, Canada
Ain Shams University

Completed

Prophylactic Mirtazapine or Dexamethasone for Post-spinal Anesthesia Shivering

Shivering

Egypt
Novartis Pharmaceuticals

Completed

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Chronic Hepatitis C Genotype-1 Relapse

Belgium, United States, Germany, Spain, Puerto Rico, Taiwan, Australia
Foundation for Innovative New Diagnostics, Switzerland
UNITAID

Completed

Evaluation of Dried Blood Spot for HCV RNA Testing

Hepatitis C, Chronic

Australia, Cameroon, Georgia, Greece, Rwanda
University of California, San Diego
National Institute on Drug Abuse (NIDA); Open Society Foundations; UCSD Center... and other collaborators

Completed

Police Training to Reduce Occupational Needlesticks and HIV Among Substance Users (ESCUDO)

Occupational Needlestick Injuries

Mexico
Gilead Sciences

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

Chronic Hepatitis C Virus

United States, Puerto Rico
Boston Medical Center
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Integrating HCV and HIV Screening During the Era of HIV Antigen Testing

Hepatitis C | HIV

United States
Getz Pharma

Completed

Direct Acting Anti-Viral's In Chronic HCV Patients

Safety Issues

Pakistan
Radboud University Medical Center

Withdrawn

Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet (CRUSADE-1)

HCV

Netherlands, Germany
Radboud University Medical Center

Completed

A Drug-drug Interaction Study Between Daclatasvir and Metformin (DATE-3)

Diabetes Mellitus | Hepatitis C | Insulin Resistance

Netherlands
Radboud University Medical Center
University Medical Center Groningen; Maastricht University Medical Center; UMC... and other collaborators

Completed

Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens (RIBACOP)

Hepatitis C | HCV Coinfection

Netherlands
David Garcia Cinca
Dr. Josep Mallolas

Unknown

Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study (DORAVIPEP)

Hiv

Spain, France
Kowa Company, Ltd.

Completed

Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC

Hepatic Neoplasm Malignant Recurrent

Japan
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO) (PROMO)

HCV Infections | Gastric Acid-related Disorders

Netherlands
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir (OPAL)

HIV Infections | HCV Infections

Netherlands
King Fahad Medical City

Completed

Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4 (ELEGANT-4)

Hepatitis C, Chronic

Saudi Arabia
Oregon Health and Science University

Completed

Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care

Substance Abuse, Intravenous | Hepatitis C | Substance Use Disorders

United States
National Taiwan University Hospital
National Taiwan University Hospital Yunlin Branch

Unknown

Application of 18F-FDOPA PET in Research of the Association Between HCV Infection and Parkinson's Disease.

Hepatitis C

Taiwan
University of Aarhus
AbbVie; Aarhus University Hospital

Completed

Macrophages, Portal Hypertension, and Liver Function During AbbVie Treatment of Chronic Hepatitis C

Hepatitis C

Denmark
Gilead Sciences

Terminated

Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection

Hepatitis C Virus Infection

Poland, Italy, United Kingdom
Phillip Coffin, MD, MIA
National Institute on Drug Abuse (NIDA)

Completed

Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs (BYE-C)

Chronic Hepatitis C

United States
Sherief Abd-Elsalam
Benha University

Unknown

Effect of Direct-acting Antiviral Drugs on Erectile Function

Hepatitis C

Egypt
The First Hospital of Jilin University
Chinese Academy of Sciences

Completed

HCV Epidemiological Survey in China Rural Area (HCVES)

Hepatitis

China
Radboud University Medical Center

Completed

Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole. (COPA)

Hepatitis C | Swallowing Disorder

Netherlands
AbbVie

Completed

A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs (HCV PMS)

Hepatitis C Virus (HCV)

Korea, Republic of
Gilead Sciences

Completed

Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection

Hepatitis C Virus Infection

United States, Belgium, Italy, United Kingdom
University Hospital, Clermont-Ferrand
Merck Sharp & Dohme LLC

Completed

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis (STREAGER)

Chronic HCV Infection

France
Imperial College London
Institut National de la Santé Et de la Recherche Médicale, France; Medical... and other collaborators

Completed

PROLIFICA - West African Treatment Cohort for Hepatitis B (WATCH)

Hepatocellular Carcinoma | Hepatitis B, Chronic

Gambia, Senegal
M.D. Anderson Cancer Center
Vertex Pharmaceuticals Incorporated

Terminated

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Infection

United States
M.D. Anderson Cancer Center
Ortho Biotech, Inc.

Completed

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

Lymphoma

United States
Bayside Health
Merck Sharp & Dohme LLC; Austin Hospital, Melbourne Australia

Withdrawn

HepATocellular Cancer Hcv Therapy Study (HATCHeT)

Hepatocellular Carcinoma | Hepatitis C | Hepatoma | Liver Cell Carcinoma
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects (HEC110114)

Chronic Hepatitis C

China
Gilead Sciences

Completed

Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

HCV Infection

New Zealand
Bristol-Myers Squibb

Completed

Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia (MAGNITUDE)

Hepatitis C Virus

Australia, France, United States, Spain, Italy, Netherlands, Romania, Russian Federation
Ascletis Pharmaceuticals Co., Ltd.

Completed

Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.

HCV

China
Columbia University
Boston University; National Institute on Drug Abuse (NIDA); Johns Hopkins University and other collaborators

Completed

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S. (CTN 0064)

Hepatitis C | HIV | Substance Use | AIDS

United States
Foundation for Innovative New Diagnostics, Switzerland
The National Center for Disease Control and Public Health; Health Research...

Completed

Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia (HEAD-Start)

Hepatitis C, Chronic

Georgia
TaiwanJ Pharmaceuticals Co., Ltd

Terminated

Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies (JKB122)

Chronic Hepatitis C

Taiwan
AbbVie

Completed

A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis (EXPEDITION-8)

Hepatitis C Virus (HCV)

United States, Bulgaria, Canada, Czechia, France, Greece, Hungary, Ireland, Israel, Italy, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom, Vietnam

Search clinical trials for: HCV GT1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations